PMID- 31077652 OWN - NLM STAT- MEDLINE DCOM- 20200129 LR - 20200801 IS - 1555-7162 (Electronic) IS - 0002-9343 (Print) IS - 0002-9343 (Linking) VI - 132 IP - 8 DP - 2019 Aug TI - Presentation and Mortality of Cryptococcal Infection Varies by Predisposing Illness: A Retrospective Cohort Study. PG - 977-983.e1 LID - S0002-9343(19)30391-2 [pii] LID - 10.1016/j.amjmed.2019.04.026 [doi] AB - BACKGROUND: Cryptococcal epidemiology is changing in the modern antiretroviral era, and immune status informs outcomes. We describe the differences in clinical presentation and mortality of cryptococcosis by immune status in the antiretroviral therapy era. METHODS: We conducted a single-center retrospective cohort study of patients diagnosed with cryptococcosis from 2002 through 2017. Data included demographics, clinical features, diagnostics, and mortality. RESULTS: We identified 304 patients with Cryptococcus neoformans infections: 105 (35%) were people living with human immunodeficiency virus (HIV), 41 (13%) had a history of transplantation, and 158 (52%) were non-HIV nontransplant (NHNT). Age analysis showed that people living with HIV were younger (40 years) than transplant (53 years) and NHNT (61 years) (P < .001). Fevers and headache were more common in people living with HIV (70% and 57%) than in transplant (49% and 29%) and NHNT (49% and 38%) (P = .003 and P = .001), respectively. Meningitis was more common in people living with HIV (68%) than in transplant recipients (32%) or NHNT (39%, P < .001). Disseminated cryptococcosis was more common in people living with HIV (97%) as compared with transplant (66%) or NHNT (73%) (P < .001). Time to diagnosis from hospitalization was longer for transplant (median 2 days, interquartile range [IQR] +/- 9 days) and NHNT patients (median 2 days, IQR +/- 7 days) as compared with people living with HIV (median 1 day, IQR +/- 2 days) (P = .003). NHNT patients had a higher risk of 90-day mortality (hazard ratio 3.3; 95% confidence interval, 1.9-5.8) as compared with people living with HIV. CONCLUSIONS: The majority of cryptococcosis occurs in NHNT patients. NHNT patients had more localized pulmonary cryptococcosis and significantly higher 90-day mortality. Cryptococcosis in NHNT patients appears to be a distinct entity that needs further study and requires a higher level of clinical suspicion than it currently receives. CI - Copyright (c) 2019 Elsevier Inc. All rights reserved. FAU - Hevey, Matthew A AU - Hevey MA AD - Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Mo. Electronic address: matthewhevey@gmail.com. FAU - George, Ige A AU - George IA AD - Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Mo. FAU - Raval, Krunal AU - Raval K AD - Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Mo. FAU - Powderly, William G AU - Powderly WG AD - Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Mo. FAU - Spec, Andrej AU - Spec A AD - Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, St. Louis, Mo. LA - eng GR - UL1 TR002345/TR/NCATS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20190508 PL - United States TA - Am J Med JT - The American journal of medicine JID - 0267200 SB - IM MH - Adult MH - Cohort Studies MH - Cryptococcosis/etiology/*mortality MH - Cryptococcus neoformans/drug effects/pathogenicity MH - Female MH - HIV Infections/complications MH - Humans MH - Male MH - Middle Aged MH - Organ Transplantation/adverse effects/methods MH - Proportional Hazards Models MH - Retrospective Studies MH - Risk Factors MH - Statistics, Nonparametric PMC - PMC6744315 MID - NIHMS1529317 OTO - NOTNLM OT - Adult OT - Cryptococcus OT - HIV OT - Mortality OT - Presentation OT - Prognosis OT - Transplant EDAT- 2019/05/12 06:00 MHDA- 2020/01/30 06:00 PMCR- 2020/08/01 CRDT- 2019/05/12 06:00 PHST- 2018/11/03 00:00 [received] PHST- 2019/04/16 00:00 [revised] PHST- 2019/04/20 00:00 [accepted] PHST- 2019/05/12 06:00 [pubmed] PHST- 2020/01/30 06:00 [medline] PHST- 2019/05/12 06:00 [entrez] PHST- 2020/08/01 00:00 [pmc-release] AID - S0002-9343(19)30391-2 [pii] AID - 10.1016/j.amjmed.2019.04.026 [doi] PST - ppublish SO - Am J Med. 2019 Aug;132(8):977-983.e1. doi: 10.1016/j.amjmed.2019.04.026. Epub 2019 May 8.